Moneycontrol PRO

you are here: HomeNewsBusinessEarningsSun Pharma Q1 profit soars 266% to Rs 2034cr, EBITDA surges 65%

SHOW NAMES

Trending Topics

business

Sun Pharma Q1 profit soars 266% to Rs 2034cr, EBITDA surges 65%

The boost in bottomline was also on account of low base in year-ago period. The company had reported an exceptional loss of Rs 685.2 crore in Q1FY16 on account of integration and optimisation measures post Ranbaxy acquisition.

first published: Aug 12, 2016 02:07 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347